Findings reveal that MHC class II expression by intestinal epithelial cells dictates Th1 cell differentiation in graft-versus-host disease.
Key Points
This research explores the role of MHC class II expression in intestinal epithelial cells during graft-versus-host disease after bone marrow transplantation.
Utilized male antigen reactive T cells in a mouse model to understand GVHD dynamics with MHC-II manipulation.
Assessed the survival rates of mice with different MHC-II expression before and after bone marrow transplantation.
Measured donor T cell activation and differentiation in recipient intestines post-transplant.
Mice with pre-transplant MHC-II deletion had improved survival rates from GVHD (11% vs 58% survival).
MHC-II expression on intestinal epithelial cells is crucial for T cell-mediated GVHD initiation.
Depletion of MHC-I had no significant impact on GVHD outcomes compared to MHC-II depletion.